Yeah, I get that idea, just cant see it for a limited study in mouse models. Surely that sort of advantage is evident only when you are delivering quantities at the scale required for human deployment? Anyway, if it proves to show up this easily, then perhaps it could be due to that.
Ann: CYP MSC Data in Asthma Model Published in Sceintific Journal, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.28M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 16.0¢ | $29.18K | 176.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 66467 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 65000 | 1 |
View Market Depth
| Last trade - 15.59pm 25/07/2025 (20 minute delay) ? |
| CYP (ASX) Chart |